Subscribe To
EVAX / Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10
EVAX News
By Zacks Investment Research
September 21, 2023
Evaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab
Evaxion's (EVAX) shares gain as it collaborates with Afrigen Biologics to develop prophylactic mRNA vaccine targeting gonorrhea, based on Evaxion's ED more_horizontal
By Seeking Alpha
August 22, 2023
Evaxion Biotech A/S (EVAX) Q2 2023 Earnings Call Transcript
Evaxion Biotech A/S (EVAX) Q2 2023 Earnings Conference Call August 22, 2023 10:00 AM ET Company Participants Per Norlen - Chief Executive Officer Jesp more_horizontal
By GlobeNewsWire
December 15, 2022
Evaxion to present a full clinical readout on two personalized cancer immunotherapies in Q2 2023
COPENHAGEN, Denmark, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biote more_horizontal
By Seeking Alpha
August 10, 2022
Evaxion Biotech A/S (EVAX) CEO Lars Wegner on Q2 2022 Results - Earnings Call Transcript
Evaxion Biotech A/S (EVAX) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ET Company Participants Corey Davis - Managing Director, Investor more_horizontal
By GlobeNewsWire
July 29, 2022
Evaxion Biotech to Host Q2 2022 Corporate Update Conference Call & Webcast on August 10
COPENHAGEN, Denmark, July 29, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biote more_horizontal
By Seeking Alpha
May 11, 2022
Evaxion Biotech A/S' (EVAX) CEO Lars Wegner on Q1 2022 Results - Earnings Call Transcript
Evaxion Biotech A/S (EVAX) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Corey Davis – LifeSci Advisors Lars Wegner more_horizontal